Inactive Instrument
Protide Pharmaceuticals, Inc. Stock Other OTC
Stocks
PPMD
US74371A1034
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -75.00% |
| Manager | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CEO | Chief Executive Officer | 70 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Milo R. Polovina
CHM | Chairman | 70 | 18/02/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -75.00% | -75.00% | - | - | 886K | |
| -0.32% | -5.97% | +57.78% | +74.48% | 70.44B | |
| +0.81% | -13.67% | +5.36% | +54.04% | 50.31B | |
| +2.79% | +1.07% | +11.46% | +36.92% | 47.51B | |
| -0.58% | +0.27% | +27.93% | +30.76% | 42.91B | |
| -2.84% | -5.72% | +286.54% | +530.02% | 40.39B | |
| -0.38% | -3.78% | +6.74% | +95.25% | 39.69B | |
| -0.39% | -1.48% | +10.41% | +43.19% | 30.59B | |
| -2.95% | -12.28% | +43.51% | +1.51% | 26.8B | |
| -7.13% | -7.02% | -12.99% | -14.07% | 22.36B | |
| Average | -8.60% | -5.65% | +48.53% | +94.68% | 41.22B | |
| Weighted average by Cap. | -0.69% | -5.61% | +51.53% | +100.47% |
Employees
-
